BORIS peptide (ab22203)
Our Abpromise guarantee covers the use of ab22203 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
This peptide can be used with studies using ab18337.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- BORIS like proteinBrother of the regulator of imprinted sitesCancer/testis antigen 27
- CCCTC binding factor (zinc finger protein) likeCCCTC-binding factorCT27CTCF paralogCTCF TCTCF-like proteinCTCFLCTCFL_HUMANdJ579F20.2HMG 1L1HMGB1L1MGC163358MGC169105MGC169106Putative high mobility group protein 1 like 1Putative high mobility group protein B1 like 1Transcriptional repressor CTCFLZinc finger protein CTCF-T
Contains 11 C2H2-type zinc fingers.
References for BORIS peptide (ab22203)
This product has been referenced in:
- Woloszynska-Read A et al. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res 17:2170-80 (2011). Blocking . Read more (PubMed: 21296871) »
- Jones TA et al. Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells. PLoS One 6:e22399 (2011). Blocking . Read more (PubMed: 21811597) »